rxstat › Shortages › Ranitidine

Ranitidine shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Ranitidine products are in shortage in Canada (12 of 36 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 30, 2022.
Products affected
12 / 36
In shortage since
Mar 10, 2017
Est. full return
Dec 30, 2022
Reports on file
127
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
PMS-RANITIDINE 300 MG
300MG · TABLET · PHARMASCIENCE INC
DIN 02242454 · since Oct 23, 2019, no end estimate · Disruption of the manufacture of the drug.
Active shortage
PMS-RANITIDINE 150 MG
150MG · TABLET · PHARMASCIENCE INC
DIN 02242453 · since Oct 23, 2019, no end estimate · Disruption of the manufacture of the drug.
Active shortage
PMS-RANITIDINE 150 MG
150MG · TABLET · PHARMASCIENCE INC
DIN 02242453 · since Oct 23, 2019, no end estimate · Disruption of the manufacture of the drug.
Active shortage
PMS-RANITIDINE 150 MG
150MG · TABLET · PHARMASCIENCE INC
DIN 02242453 · since Oct 23, 2019, no end estimate · Disruption of the manufacture of the drug.
Active shortage
JAMP-RANITIDINE
300MG · TABLET · JAMP PHARMA CORPORATION
DIN 02463725 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-RANITIDINE
150MG · TABLET · JAMP PHARMA CORPORATION
DIN 02463717 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-RANITIDINE
150MG · TABLET · JAMP PHARMA CORPORATION
DIN 02463717 · since Oct 7, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
APO-RANITIDINE
15MG · SOLUTION · APOTEX INC
DIN 02280833 · since Sep 17, 2019, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-RANITIDINE TABLET 300MG
300MG · TABLET · APOTEX INC
DIN 00733067 · since Sep 17, 2019, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-RANITIDINE TABLET 150MG
150MG · TABLET · APOTEX INC
DIN 00733059 · since Sep 17, 2019, no end estimate · Disruption of the manufacture of the drug.
Active shortage
RANITIDINE
300MG · TABLET · SANIS HEALTH INC
DIN 02353024 · since Sep 16, 2019, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
RANITIDINE
150MG · TABLET · SANIS HEALTH INC
DIN 02353016 · since Sep 16, 2019, no end estimate · Requirements related to complying with good manufacturing practices.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Ranitidine is currently affected by 12 active shortage reports filed with Health Canada by PHARMASCIENCE INC, JAMP PHARMA CORPORATION, APOTEX INC, SANIS HEALTH INC and 1 others.

The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices; other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ranitidine is classified under “DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)” (ATC A02BA).

Recent changes

Common questions

When will Ranitidine be back in stock in Canada?

The latest manufacturer estimate is Dec 30, 2022. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Ranitidine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (drugs for peptic ulcer and gastroesophageal reflux disease (gerd))

Widespread shortageFamotidine3 of 13 reported products affected · est. return Sep 18, 2026Partial shortageCimetidine3 of 9 reported products affectedPartial shortageEsomeprazole12 of 26 reported products affected · est. return Oct 10, 2027Partial shortageLansoprazole6 of 22 reported products affected · est. return Dec 29, 2026Partial shortageOmeprazole10 of 22 reported products affected · est. return Aug 14, 2026Partial shortagePantoprazole7 of 35 reported products affected · est. return Sep 29, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.